As prognosis in patients with metastatic disease can be influenced by a variety of factors, we analyzed the characteristic and prognostic value of HER2 expression in 2783 patients with histologically confirmed stage I-III colorectal cancer in multiple centers. Here, ERBB2 is linked to colorectal cancer.